Pfizer Inc. has voluntarily initiated a Class II recall of Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL) supplied in vials and distributed by its Hospira division. The recall affects 49,620 vials nationwide across the United States.
Pfizer Inc. has voluntarily initiated a Class II recall of Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL) supplied in vials and distributed by its Hospira division. The recall affects 49,620 vials nationwide across the United States.
Cipla USA, Inc. has voluntarily initiated a Class III recall of its Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 metered inhalations, 6.7 g canisters) following quality concerns identified during routine testing. The product was...
Cipla USA, Inc. has voluntarily initiated a Class III recall of its Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 metered inhalations, 6.7 g canisters) following quality concerns identified during routine testing. The product was...
The US Food and Drug Administration (FDA) has announced a Class II drug recall involving two separate lots of Xolair (omalizumab injection), a biologic produced by Genentech, Inc.
The US Food and Drug Administration (FDA) has announced a Class II drug recall involving two separate lots of Xolair (omalizumab injection), a biologic produced by Genentech, Inc.
